A Study of the Efficacy and Safety of Pregabalin for the Treatment of Fibromyalgia
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of pregabalin versus placebo
for the symptomatic relief of pain associated with fibromyalgia. If this objective is met,
then the second objective will be to evaluate the efficacy and safety of pregabalin versus
placebo for the management of fibromyalgia (pain, patient global assessment, and functional
status). Additionally, the study will evaluate the efficacy of pregabalin versus placebo to
improve sleep, fatigue, and mood disturbance associated with fibromyalgia.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.